Company profile: Xeltis
1.1 - Company Overview
Company description
- Provider of polymer-based restorative cardiovascular devices, including implantable small-diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft surgery, and pulmonary heart valves. Products include aXess; XABG/Xabg; and Xplore-2, designed to transform into a living valve made of the patient’s own tissue, aiming to reduce reintervention rates.
Products and services
- XABG: A polymer-based restorative conduit for coronary artery bypass surgery, constructing a small-diameter graft that becomes a long-term living vessel to improve coronary blood flow
- AXess: An implantable vascular access conduit for hemodialysis, building a small-diameter channel that develops into a durable, long-term living vessel for dialysis vascular access
- Xplore-2: A polymer-based restorative pulmonary heart valve engineered to transform into a living valve of the patient’s own tissue, aiming to reduce reintervention rates
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xeltis
Hyloris Pharmaceuticals
HQ: Belgium
Website
- Description: Provider of specialty pharmaceutical therapies, including Sotalol IV for atrial fibrillation (developed with AltaThera), Maxigesic IV, a non-opioid analgesic for post-operative pain combining paracetamol and ibuprofen sodium dihydrate (developed with AFT Pharmaceuticals), and Podofilox Gel 0.5% for anogenital warts, equivalent to Condylox.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hyloris Pharmaceuticals company profile →
Centese
HQ: United States
Website
- Description: Provider of cardiothoracic post-operative medical equipment for surgical care and patient monitoring, including Thoraguard, a compact all-in-one system with digital monitor, suction control, canister, and chest tubes. Features automated chest tube clog clearance, precise digital air leak rate monitoring, hourly drainage volume trends, and self-monitoring alerts for cardiac and thoracic surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centese company profile →
Biosense Webster
HQ: United States
Website
- Description: Provider of technologies for diagnosing and treating heart rhythm disorders, partnering with clinicians to improve care for arrhythmia patients worldwide. Products include QDOT MICRO™ Catheters, THERMOCOOL SMARTTOUCH® SF Catheter, CARTO™ 3 Navigation System, and VISITAG SURPOINT™ Module. Part of the Johnson & Johnson Family of Companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosense Webster company profile →
AccessClosure
HQ: United States
Website
- Description: Provider of access site management products for vascular closure during interventional and diagnostic procedures, including the Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble, extravascular sealant.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AccessClosure company profile →
Hotspur
HQ: United States
Website
- Description: Provider of catheter-based technologies to restore blood flow in patients with obstructed vessels, leveraging unique, groundbreaking technology to open blood vessels more efficiently and less invasively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hotspur company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xeltis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xeltis
2.2 - Growth funds investing in similar companies to Xeltis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xeltis
4.2 - Public trading comparable groups for Xeltis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →